Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

Background/Aims: Lipoproteins have been reported to be associated with prognosis in various cancers; however, the prognostic value of lipoproteins in patients with nasopharyngeal carcinoma (NPC) remains largely unknown. We aim to asses the role of circulating lipoproteins in locoregionally advanced...

Full description

Bibliographic Details
Main Authors:	Ji-Jin Yao, Xiao-Jun He, Wayne R. Lawrence, Wang-Jian Zhang, Jia Kou, Fan Zhang, Guan-Qun Zhou, Si-Yang Wang, Ying Sun
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-07-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Nasopharyngeal carcinoma Locoregionally advanced Lipoprotein Ratio Prognostic value
Online Access:	https://www.karger.com/Article/FullText/491728

Similar Items

Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
by: Weiling Qu, et al.
Published: (2023-03-01)

The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Tao-xiang Huang, et al.
Published: (2019-05-01)

The long-term survival of the doublet regimen of concurrent chemoradiation therapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Zhi-Qiang Wang, et al.
Published: (2022-11-01)

Clinical Observation of Concurrent Radio-Chemotherapy Combined with Adjuvant Chemotherapy in Treating Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yan-ping CHEN, Yun-cong LIU, et al.
Published: (2010-02-01)

A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
by: Wang R, et al.
Published: (2024-07-01)

An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling
by: Jiayu Zhou, et al.
Published: (2023-05-01)

Survival after induction chemotherapy in locoregional advanced nasopharyngeal carcinoma: An updated systematic review and meta‐analysis
by: Yiyu Meng, et al.
Published: (2023-10-01)

Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Zhao R, et al.
Published: (2022-05-01)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)

Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma
by: Feng Li, et al.
Published: (2020-08-01)

Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
by: Hao‐Yun Tao, et al.
Published: (2023-03-01)

An overall survival predictive nomogram to identify high-risk patients among locoregionally advanced nasopharyngeal carcinoma: Developed based on the SEER database and validated institutionally
by: Yinbing Lin, et al.
Published: (2023-03-01)

Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials
by: Farida Nazeer, et al.
Published: (2022-01-01)

Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area
by: Ji-Jin Yao, et al.
Published: (2019-01-01)

Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma
by: Ge Yan, et al.
Published: (2022-06-01)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
by: Shu Liao, et al.
Published: (2022-06-01)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer
by: Aline Van der Vorst, et al.
Published: (2022-08-01)

Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
by: Qun Zhang, et al.
Published: (2023-01-01)

A nomogram with Nottingham prognostic index for predicting locoregional recurrence in breast cancer patients
by: Jianqing Zheng, et al.
Published: (2024-09-01)

Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis
by: Zhe Dong, et al.
Published: (2024-04-01)

Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis
by: Yuyi Yao, et al.
Published: (2023-01-01)

Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
by: Jingjing Miao, et al.
Published: (2023-04-01)

Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review
by: Yingna Gao, et al.
Published: (2025-01-01)

A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment
by: Ying-Hong Wei, et al.
Published: (2022-06-01)

Can the apparent transverse relaxation rate (R2*) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experience
by: Xinhua Xu, et al.
Published: (2023-06-01)

Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
by: Ji-Jin Yao, et al.
Published: (2018-12-01)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
by: Hongjia Liu, et al.
Published: (2023-03-01)

Intravenous Locoregional Anesthesia: An Alternative of Choice in a Country with Limited Resources (Abidjan- Cote d'Ivoire)
by: Nkan Michael Paterne Mobio, et al.
Published: (2022-06-01)

Factors associated with locoregional recurrence in penile cancer: a case-control study
by: Aldo Zárate-González, et al.
Published: (2021-01-01)

Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer
by: Shi W, et al.
Published: (2019-05-01)

Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure
by: Xing-Li Yang, et al.
Published: (2022-11-01)

The prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer
by: Mustafa Kandaz, et al.
Published: (2025-01-01)

Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy
by: Moonkyoo Kong, et al.
Published: (2022-09-01)

Advanced nasopharyngeal carcinoma in children
by: Wan-Chen Kao, et al.
Published: (2016-09-01)

The prognostic value of integration of pretreatment serum amyloid A (SAA)–EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma
by: Jianpei Li, et al.
Published: (2020-01-01)

A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy
by: Minying Li, et al.
Published: (2022-06-01)

The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
by: Singh P, et al.
Published: (2020-02-01)

Rectal Cancer and Lateral Lymph Node Staging: Interobserver Agreement and Success in Predicting Locoregional Recurrence
by: Hüseyin Akkaya, et al.
Published: (2024-11-01)

Prognostic value of tumor burden in nasopharyngeal carcinoma
by: Chen CB, et al.
Published: (2018-09-01)

Immune cells within tertiary lymphoid structures are associated with progression‐free survival in patients with locoregional recurrent breast cancer
by: Jinyuan Gu, et al.
Published: (2024-01-01)